Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-07-09 Sale | 2020-07-13 6:27 pm | ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner | 2,241 | $102.28 | $229,209 | 7,008,510 (Direct) | View |
2020-07-01 Purchase | 2020-07-06 5:24 pm | ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner | 108,108 | $92.5 | $9,999,990 | 6,971,772 (Direct) | View |
2019-11-12 Purchase | 2019-11-14 4:06 pm | AGIOS PHARMACEUTICALS INC. | AGIO | CELGENE CORP Celgene European Investment Co LLC Celgene Switzerland LLC Celgene Alpine Investment Co. LLC 10% Owner | 403,225 | $31 | $12,499,975 | 7,121,658 (Indirect Direct) | View |
2019-09-18 Sale | 2019-09-19 4:05 pm | CELGENE CORP | CELG | Curran Terrie SEE REMARKS | 11,338 | $98.27 | $1,114,144 | 5,153 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2020-07-09 Exercise | 2020-07-13 6:27 pm | N/A 2020-07-09 | ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner | 38,979 | $0 | 7,008,510 (Direct) | View |
2020-07-09 Exercise | 2020-07-13 6:27 pm | N/A N/A | ACCELERON PHARMA INC | XLRN | CELGENE CORP BRISTOL MYERS SQUIBB CO 10% Owner | 38,979 | $5.88 | 7,008,510 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2025-02-02 | CELGENE CORP | CELG | VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | 335,935 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | 46,749 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2027-01-30 | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 94,975 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2022-01-30 | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 142,098 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 25,875 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2022-03-01 | CELGENE CORP | CELG | Alles Mark J CEO, CHAIRMAN OF BOARD | 679,555 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Alles Mark J CEO, CHAIRMAN OF BOARD | 145,229 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2026-10-31 | CELGENE CORP | CELG | Alles Mark J CEO, CHAIRMAN OF BOARD | 554,328 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2028-08-01 | CELGENE CORP | CELG | Elkins David V EVP, CHIEF FINANCIAL OFFICER | 250,777 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Elkins David V EVP, CHIEF FINANCIAL OFFICER | 43,224 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 43,745 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2023-05-01 | CELGENE CORP | CELG | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 175,619 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 32,868 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2028-07-30 | CELGENE CORP | CELG | Biller Jonathan EVP AND GENERAL COUNSEL | 59,752 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2023-10-28 | CELGENE CORP | CELG | Biller Jonathan EVP AND GENERAL COUNSEL | 108,282 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | Biller Jonathan EVP AND GENERAL COUNSEL | 20,387 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:31 am | N/A 2028-11-01 | CELGENE CORP | CELG | REICIN ALISE PRES., GLOBAL CLINICAL DEV. | 148,582 | $0 | 0 (Direct) | View |
2019-11-20 Option Award | 2019-11-22 07:31 am | N/A N/A | CELGENE CORP | CELG | REICIN ALISE PRES., GLOBAL CLINICAL DEV. | 37,434 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2020-06-16 | CELGENE CORP | CELG | LOUGHLIN JAMES J Director | 197,687 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2025-10-15 | CELGENE CORP | CELG | Haller Julia A Director | 53,201 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2023-06-12 | CELGENE CORP | CELG | Friedman Michael A Director | 94,939 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2021-06-15 | CELGENE CORP | CELG | COX CARRIE SMITH Director | 176,236 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2024-07-01 | CELGENE CORP | CELG | MARIO ERNEST Director | 139,284 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2020-06-16 | CELGENE CORP | CELG | CASEY MICHAEL D Director | 295,596 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2025-04-14 | CELGENE CORP | CELG | BONNEY MICHAEL W Director | 66,001 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2028-04-17 | CELGENE CORP | CELG | Hall Patricia Hemingway Director | 29,476 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2028-02-13 | CELGENE CORP | CELG | WEILAND JOHN H Director | 35,051 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2028-04-18 | CELGENE CORP | CELG | Bishop Hans Edgar Director | 52,564 | $0 | 0 (Direct) | View |
2019-11-20 Disposition | 2019-11-22 07:30 am | N/A 2022-01-20 | CELGENE CORP | CELG | BARKER RICHARD W Director | 124,513 | $0 | 0 (Direct) | View |
2019-10-29 Exercise | 2019-11-06 4:05 pm | N/A N/A | CELGENE CORP | CELG | COX CARRIE SMITH Director | 12,500 | $25.89 | 39,535 (Direct) | View |
2019-10-29 Tax Withholding | 2019-11-06 4:05 pm | N/A N/A | CELGENE CORP | CELG | COX CARRIE SMITH Director | 3,045 | $106.3 | 39,535 (Direct) | View |
2019-10-29 Exercise | 2019-11-06 4:05 pm | N/A 2019-12-16 | CELGENE CORP | CELG | COX CARRIE SMITH Director | 12,500 | $0 | 39,535 (Direct) | View |
2019-11-01 Tax Withholding | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | REICIN ALISE PRES., GLOBAL CLINICAL DEV. | 4,722 | $108.53 | 30,988 (Direct) | View |
2019-11-01 Exercise | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | REICIN ALISE PRES., GLOBAL CLINICAL DEV. | 11,903 | $0 | 30,988 (Direct) | View |
2019-10-31 Tax Withholding | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | VESSEY RUPERT SEE REMARKS | 2,644 | $108.03 | 14,791 (Direct) | View |
2019-10-31 Exercise | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | VESSEY RUPERT SEE REMARKS | 5,369 | $0 | 14,791 (Direct) | View |
2019-10-31 Tax Withholding | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | Curran Terrie SEE REMARKS | 1,123 | $108.03 | 5,239 (Direct) | View |
2019-10-31 Exercise | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | Curran Terrie SEE REMARKS | 3,281 | $0 | 5,239 (Direct) | View |
2019-10-31 Tax Withholding | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 1,096 | $108.03 | 16,785 (Direct) | View |
2019-10-31 Exercise | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 3,281 | $0 | 16,785 (Direct) | View |
2019-10-31 Tax Withholding | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | Biller Jonathan EVP AND GENERAL COUNSEL | 1,044 | $108.03 | 7,143 (Direct) | View |
2019-10-31 Exercise | 2019-11-04 4:05 pm | N/A N/A | CELGENE CORP | CELG | Biller Jonathan EVP AND GENERAL COUNSEL | 3,125 | $0 | 7,143 (Direct) | View |
2019-09-18 Exercise | 2019-09-19 4:05 pm | N/A N/A | CELGENE CORP | CELG | Curran Terrie SEE REMARKS | 4,500 | $58.33 | 5,153 (Direct) | View |
2019-09-18 Exercise | 2019-09-19 4:05 pm | N/A 2023-05-01 | CELGENE CORP | CELG | Curran Terrie SEE REMARKS | 4,500 | $0 | 5,153 (Direct) | View |
2019-08-01 Tax Withholding | 2019-08-05 4:00 pm | N/A N/A | CELGENE CORP | CELG | Elkins David V EVP, CHIEF FINANCIAL OFFICER | 11,039 | $93.05 | 63,998 (Direct) | View |
2019-08-01 Exercise | 2019-08-05 4:00 pm | N/A N/A | CELGENE CORP | CELG | Elkins David V EVP, CHIEF FINANCIAL OFFICER | 24,947 | $0 | 63,998 (Direct) | View |
2019-06-13 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | CASEY MICHAEL D Director | 1,159 | $0 | 144,908 (Direct) | View |
2019-06-13 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | MARIO ERNEST Director | 1,159 | $0 | 69,062 (Direct) | View |
2019-06-13 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | Friedman Michael A Director | 1,159 | $0 | 21,117 (Direct) | View |
2019-06-13 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | LOUGHLIN JAMES J Director | 3,225 | $0 | 46,999 (Direct) | View |
2019-06-15 Tax Withholding | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | BARKER RICHARD W Director | 336 | $96.51 | 13,337 (Direct) | View |
2019-06-15 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | BARKER RICHARD W Director | 1,125 | $0 | 13,337 (Direct) | View |
2019-06-13 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | BONNEY MICHAEL W Director | 1,159 | $0 | 5,479 (Direct) | View |
2019-06-13 Exercise | 2019-06-17 4:00 pm | N/A N/A | CELGENE CORP | CELG | Haller Julia A Director | 1,159 | $0 | 3,679 (Direct) | View |